Bonesupport Holding AB (publ) (LON:0RQO)

Market Cap	1.18B -17.4%
Revenue (ttm)	96.70M +21.8%
Net Income	14.73M +51.3%
EPS	0.22 +50.7%
Shares Out	n/a
PE Ratio	79.93
Forward PE	41.70
Dividend	n/a
Ex-Dividend Date	n/a

Volume	261
Open	220.40
Previous Close	220.22
Day's Range	218.40 - 220.40
52-Week Range	167.55 - 345.80
Beta	0.48
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 16, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone gra...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Employees: 160
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RQO

Financial Performance

In 2025, Bonesupport Holding AB's revenue was 1.17 billion, an increase of 30.70% compared to the previous year's 898.73 million. Earnings were 142.15 million, an increase of 6.28%.

Financial numbers in SEK